Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection

Nature

Volumn 315, Issue 6017, 1985, Pages 301-305

  Wallich, R ^a   Bulbuc, N ^a,b   Hammerling G J ^b,c   Katzav, S ^b,c   Segal, S ^a   Feldman, M ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; FIBROSARCOMA; GENETIC TRANSFECTION; HEREDITY; IMMUNOGENICITY; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY; TUMOR CELL;

ANIMALS; H-2 ANTIGENS; IMMUNITY; MICE; MICE, INBRED STRAINS; NEOPLASM METASTASIS; RATS; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

ANIMALIA; MURINAE;

EID: 0021815478     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/315301a0     Document Type: Article

References (30)

1. Zinkernagel, R. M. and Doherty, P. C. Adv. Immun. 27, 51-177 (1979).
2. Isakov, N., Katzav, S., Feldman, M. and Segal, S. J. natn. Cancer Inst. 71, 139-145 (1983).
3. Eisenbach, L., Segal, S. and Feldman, M. Int. J. Cancer 32, 113-120 (1983).
4. De Baetselier, P., Katzav, S., Gorelik, E., Feldman, M. and Segal, S. Nature 288, 179-181 (1980).
5. Katzav, S., De Baetselier, P., Gorelik, E., Feldman, M. and Segal, S. Transplanta Proc. 13, 742-746 (1981).
6. Katzav, S., De Baetselier, P., Tartakovsky, B., Feldman, M. and Segal, S. J. natn. Cancer Inst. 71, 317-324 (1983).
7. Katzav, S. et al. Transplanta Proc. 15, 162-170 (1983).
8. Katzav, S., Segal, S. and Feldman, M. Int. J. Cancer 33, 407-415 (1984).
9. Katzav, S.S. and Feldman, M. J. natn. Cancer Inst, (in the press).
10. Mellor, A. L. et al. Nature 298, 529-534 (1982).
11. Arnold, B., Burgert, H.-G., Archibald, A. L. and Kvist, S. Nucleic Acids Res. 12, 9473-9487 (1984).
12. Colbere-Garapin, F., Horodniceanu, F., Kouritsky, P. and Garapin, A.-C. J. molec. Biol. 150, 1-14(1981).
13. Hämmerling, G. J., Rüsch, E., Tada, N., Kjmura, S. and Hämmerling, U. Proc. natn. Acad. Sa. U.S.A. 79, 4737-4741 (1982).
14. Wemet, D. and Lilly, F. J. exp. Med. 144, 266-271 (1976).
15. Wemet, D., Shafran, H. and Lilly, F. J. exp. Med. 144, 654-661 (1976).
16. Miller, S. D., Sy, M. S. and Claman, H. N. J. exp. Med. 147, 788-799 (1978).
17. Hasek, M. and Chutna, J. Immun. Rev. 46, 3-26 (1979).
18. Holtkamp, B., Fischer-Lindahl, K., Segal, M. and Rajewsky, K. Immunogenetics 9, 405-421 (1979).
19. Schmidt, W., Atfield, G. and Festenstein, H. Immunogenetics 8, 311-321 (1979).
20. Schmidt, W. Sc Festenstein, H. Immunogenetics 16, 247-264 (1982).
21. Bernards, R., Schrier, P. L, Houweling, A., Bos, J. L. and van der EB. Nature 305, 776-779 (1983).
22. Eisenbach, L. et al. Int. J. Cancer 34, 567 (1984).
23. Hui, K., Grosveld, F. and Festenstein, H. Nature 311, 750-752 (1984).
24. Sanderson, A. R. Sc Beverly, P. C. L. Immun. Today 4, No. 8 211-213 (1983).
25. Natali, P. G. et al. Cancer Res. 43, 660-668 (1983).
26. Wigler, M. et al. Proc. natn. Acad. Sei. U.S.A. 76, 1373-1376 (1979).
27. Lemke, H., Hämmerling, G. J., Höhmann, C. and Rajewsky, K. Nature 271, 249-251 (1978).
28. Lemke, H., Hämmerling, G. J. and Hämmerling, U. Immun. Rev. 47, 175-206 (1979).
29. Gorelik, E. et al Cancer Metastasis Rev. 1, 83-94 (1982).
30. O’Farrell, P. H. J. biol. Chem. 250, 4007-4012 (1975).